Tomer Kariv Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Tomer Kariv.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Tomer Kariv. Tomer Kariv is in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Eloxx Pharmaceuticals, Inc. ($ELOX) and Director in Arno Therapeutics, Inc ($ARNI) and Director in VBI Vaccines Inc/BC ($VBIV) and Director in LogicBio Therapeutics, Inc. ($LOGC) and Director in Keros Therapeutics, Inc. ($KROS) and Director in 89bio, Inc. ($ETNB).
Latest Insider Trading Transactions of Tomer Kariv
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ETNB, ARNI, ELOX, KROS, LOGC, VBIV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Option Exercise | A | 1.48 | 20,000 | 29,600 | 20,000 | ||
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 592,592 | 799,999 | 616,592 | 24 K to 616.6 K (+2,469.13 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 1,422,222 | 1,920,000 | 1,989,551 | 567.3 K to 2 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 2,630,487 | 3,551,157 | 3,679,797 | 1 M to 3.7 M (+250.69 %) |
May 17 2021 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 1.35 | 1,280,624 | 1,728,842 | 1,791,470 | 510.8 K to 1.8 M (+250.69 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 6,000 | 300,000 | 155,262 | 149.3 K to 155.3 K (+4.02 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 14,400 | 720,000 | 1,228,326 | 1.2 M to 1.2 M (+1.19 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 12,966 | 648,300 | 1,122,768 | 1.1 M to 1.1 M (+1.17 %) |
Nov 19 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 50.00 | 26,634 | 1,331,700 | 2,288,151 | 2.3 M to 2.3 M (+1.18 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 36,858 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 79,653 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 88,460 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 163,612 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 68,654 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 91,538 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 82,425 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 169,307 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 737,226 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 663,825 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 1,363,542 | 0 | 0 | |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 16.00 | 43,750 | 700,000 | 149,262 | 105.5 K to 149.3 K (+41.46 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 16.00 | 105,000 | 1,680,000 | 1,213,926 | 1.1 M to 1.2 M (+9.47 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 16.00 | 94,546 | 1,512,736 | 1,109,802 | 1 M to 1.1 M (+9.31 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | P | 16.00 | 194,203 | 3,107,248 | 2,261,517 | 2.1 M to 2.3 M (+9.39 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 36,858 | 0 | 105,512 | 68.7 K to 105.5 K (+53.69 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 79,653 | 0 | 1,108,926 | 1 M to 1.1 M (+7.74 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 88,460 | 0 | 1,015,256 | 926.8 K to 1 M (+9.54 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 163,612 | 0 | 2,067,314 | 1.9 M to 2.1 M (+8.59 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 68,654 | 0 | 68,654 | 0 to 68.7 K |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 91,538 | 0 | 1,029,273 | 937.7 K to 1 M (+9.76 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 82,425 | 0 | 926,796 | 844.4 K to 926.8 K (+9.76 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 169,307 | 0 | 1,903,702 | 1.7 M to 1.9 M (+9.76 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 737,226 | 0 | 937,735 | 200.5 K to 937.7 K (+367.68 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 663,825 | 0 | 844,371 | 180.5 K to 844.4 K (+367.68 %) |
Apr 13 2020 | KROS | Keros Therapeutics ... | Kariv Tomer | Director | Buy | C | 0.00 | 1,363,542 | 0 | 1,734,395 | 370.9 K to 1.7 M (+367.68 %) |
Dec 20 2019 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | A | 12.65 | 10,869 | 137,493 | 10,869 | |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Option Exercise | C | 0.00 | 5,500,001 | 0 | 0 | |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | C | 0.00 | 884,671 | 0 | 1,134,671 | 250 K to 1.1 M (+353.87 %) |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
Nov 13 2019 | ETNB | 89bio, Inc. | Kariv Tomer | Director | Buy | P | 16.00 | 250,000 | 4,000,000 | 250,000 | 0 to 250 K |
Jun 26 2019 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.00 | 24,000 | 216,000 | 24,000 | 0 to 24 K |
Jun 26 2019 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.00 | 46,933 | 422,397 | 567,329 | 520.4 K to 567.3 K (+9.02 %) |
Jun 26 2019 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.00 | 86,806 | 781,254 | 1,049,310 | 962.5 K to 1 M (+9.02 %) |
Jun 26 2019 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.00 | 42,261 | 380,349 | 510,846 | 468.6 K to 510.8 K (+9.02 %) |
May 29 2019 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Option Exercise | A | 9.02 | 20,000 | 180,400 | 20,000 | ||
Feb 04 2019 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Option Exercise | A | 1.64 | 200,000 | 328,000 | 200,000 | |
Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 185,714 | 260,000 | 185,714 | 0 to 185.7 K |
Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 331,429 | 464,001 | 943,451 | 612 K to 943.5 K (+54.15 %) |
Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 298,431 | 417,803 | 849,520 | 551.1 K to 849.5 K (+54.15 %) |
Dec 18 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Buy | P | 1.40 | 612,997 | 858,196 | 1,744,969 | 1.1 M to 1.7 M (+54.15 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 627,105 | 0 | 0 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 696,444 | 0 | 328,339 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | C | 0.00 | 1,288,116 | 0 | 692,982 | |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | P | 10.00 | 100,849 | 1,008,490 | 1,787,413 | 1.7 M to 1.8 M (+5.98 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | P | 10.00 | 112,000 | 1,120,000 | 1,686,564 | 1.6 M to 1.7 M (+7.11 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | P | 10.00 | 207,151 | 2,071,510 | 1,574,564 | 1.4 M to 1.6 M (+15.15 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | C | 0.00 | 328,339 | 0 | 1,367,413 | 1 M to 1.4 M (+31.60 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | C | 0.00 | 364,643 | 0 | 1,039,074 | 674.4 K to 1 M (+54.07 %) |
Oct 25 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Buy | C | 0.00 | 674,431 | 0 | 674,431 | 0 to 674.4 K |
Oct 22 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | A | 10.00 | 24,102 | 241,020 | 24,102 | |
Oct 22 2018 | LOGC | LogicBio Therapeut ... | Kariv Tomer | Director | Option Exercise | A | 10.00 | 24,102 | 241,020 | 24,102 | |
Jun 19 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Option Exercise | A | 23.27 | 40,000 | 930,800 | 40,000 | |
May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 93,333 | 909,997 | 520,396 | 427.1 K to 520.4 K (+21.85 %) |
May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 172,626 | 1,683,104 | 962,504 | 789.9 K to 962.5 K (+21.85 %) |
May 01 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 9.75 | 84,041 | 819,400 | 468,585 | 384.5 K to 468.6 K (+21.85 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 8.00 | 1,600 | 12,800 | 427,063 | 425.5 K to 427.1 K (+0.38 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 8.00 | 2,959 | 23,672 | 789,878 | 786.9 K to 789.9 K (+0.38 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 8.00 | 1,441 | 11,528 | 384,544 | 383.1 K to 384.5 K (+0.38 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 7.55 | 1,760 | 13,288 | 425,463 | 423.7 K to 425.5 K (+0.42 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 7.55 | 3,255 | 24,575 | 786,919 | 783.7 K to 786.9 K (+0.42 %) |
Mar 23 2018 | ELOX | Eloxx Pharmaceutic ... | Kariv Tomer | Director | Buy | P | 7.55 | 1,585 | 11,967 | 383,103 | 381.5 K to 383.1 K (+0.42 %) |
Jan 29 2018 | VBIV | VBI Vaccines Inc/B ... | Kariv Tomer | Director | Option Exercise | A | 4.19 | 75,000 | 314,250 | 75,000 | |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Option Exercise | P | 0.44 | 51,050 | 22,334 | 51,050 | |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Option Exercise | P | 0.44 | 131,508 | 57,535 | 131,508 | |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Option Exercise | P | 0.44 | 174,584 | 76,381 | 174,584 | |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.00 | 102,100 | 0 | 496,068 | 394 K to 496.1 K (+25.92 %) |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.00 | 263,017 | 0 | 1,277,905 | 1 M to 1.3 M (+25.92 %) |
Aug 17 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.00 | 349,168 | 0 | 1,696,495 | 1.3 M to 1.7 M (+25.92 %) |
Apr 11 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 206,986 | 72,445 | 393,968 | 187 K to 394 K (+110.70 %) |
Apr 11 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 533,208 | 186,623 | 1,014,888 | 481.7 K to 1 M (+110.70 %) |
Apr 11 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 707,868 | 247,754 | 1,347,327 | 639.5 K to 1.3 M (+110.70 %) |
Jan 14 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 206,986 | 72,445 | 393,968 | 187 K to 394 K (+110.70 %) |
Jan 14 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 533,208 | 186,623 | 1,014,888 | 481.7 K to 1 M (+110.70 %) |
Jan 14 2016 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | P | 0.35 | 707,868 | 247,754 | 1,347,327 | 639.5 K to 1.3 M (+110.70 %) |
Page: 1